Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
Rotavirus
2022
Europe
Western Pacific
Clear all
Type of publications
NITAG documentation
(39)
Systematic reviews (SYSVAC)
(15)
Topics
Available to download in languages
Regions
Europe
(37)
Western Pacific
(17)
Africa
(23)
Americas
(40)
Eastern Mediterranean
(3)
South-East Asia
(1)
Countries
Australia
(11)
Belgium
(5)
China
(6)
France
(10)
Germany
(2)
Ireland
(4)
Italy
(1)
Netherlands
(2)
Spain
(1)
Ukraine
(1)
United Kingdom
(6)
Diseases
COVID-19
(51)
Meningococcal disease
(1)
Rotavirus
(2)
Hepatitis B
(1)
Herpes zoster
(3)
Human papillomavirus (HPV)
(8)
Influenza
(5)
Japanese encephalitis
(1)
Mpox // Monkeypox
(9)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Vaccine topics
Acceptance
(7)
Coverage
(5)
Economic aspects
(2)
Efficacy/effectiveness
(2)
Ethical issues
(4)
Safety
(1)
Target population
Adolescents
(3)
Adults
(6)
All age groups
(8)
Children
(5)
Healthcare workers
(4)
Newborn
(2)
Older adults
(3)
Parents/caregivers
(3)
Pregnant women
(1)
Travellers
(1)
Publication date
2022
(54)
2024
(1)
2023
(21)
2021
(91)
2020
(36)
2019
(7)
2018
(11)
2017
(9)
2016
(7)
2015
(8)
2014
(10)
2013
(4)
2012
(1)
2011
(1)
2010
(6)
2009
(2)
2006
(5)
2001
(1)
2000
(1)
54 results found
2022
∙
Health Council of the Netherlands
Executive summary of the Second booster vaccination against COVID-19
2022
∙
ATAGI
Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19
2022
∙
JCVI
JCVI statement on COVID-19 vaccinations in 2022: 21 February 2022
2022
∙
JCVI
JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant
2022
∙
JCVI
JCVI statement on vaccination of children aged 5 to 11 years old
2022
∙
JCVI
JCVI updated statement on the COVID-19 vaccination programme for autumn 2022
2022
∙
NIAC
Medium term strategy for the COVID-19 vaccination programme
2022
∙
NIAC
NIAC recommendations for COVID-19 booster vaccination of those aged 12- 15 years
2022
∙
Haute Autorité de Santé
Revision of the rotavirus vaccine strategy and the place of Rotarix and RotaTeq vaccines
2022
∙
STIKO
Scientific justification of the STIKO for the recommendation of the 2nd COVID-19 booster vaccination with an mRNA vaccine for groups of people who are particularly at risk of health or are exposed
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register